Clinical Trials Browser

Phase 2 × NETWORK × talazoparib × Clear all

NCT03377556 2021-06-23

Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer

Phase 2 Completed

51 enrolled 18 charts

ATM Gene Mutation